Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$2.24 - $6.96 $21,392 - $66,468
-9,550 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$4.3 - $12.95 $4,377 - $13,183
-1,018 Reduced 9.63%
9,550 $60,000
Q4 2021

Feb 11, 2022

BUY
$10.0 - $16.78 $5,020 - $8,423
502 Added 4.99%
10,568 $118,000
Q3 2021

Nov 04, 2021

SELL
$15.58 - $22.88 $2,664 - $3,912
-171 Reduced 1.67%
10,066 $164,000
Q2 2021

Aug 11, 2021

BUY
$11.72 - $26.81 $78,395 - $179,332
6,689 Added 188.53%
10,237 $190,000
Q1 2021

May 13, 2021

SELL
$13.49 - $31.53 $4,694 - $10,972
-348 Reduced 8.93%
3,548 $53,000
Q4 2020

Feb 16, 2021

BUY
$7.9 - $32.3 $30,778 - $125,840
3,896 New
3,896 $126,000

Others Institutions Holding CDAK

# of Institutions
1
Shares Held
238K
Call Options Held
0
Put Options Held
0

About Codiak BioSciences, Inc.


  • Ticker CDAK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,995,200
  • Market Cap $360K
  • Description
  • Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...
More about CDAK
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.